PNTG Pennant Group, Inc.
Services-Health Services · Nasdaq · SEC CIK 1766400 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY38.7%
TTM net income YoY34.4%
TTM EPS YoY34.7%
Revenue 3-yr CAGR30.9%
Net income 3-yr CAGR42.1%
Margins
Gross margin18.3%
Operating margin5.8%
Net margin3.1%
FCF margin2.9%
EBITDA margin6.8%
Returns
ROE10.3%
ROA4.0%
ROIC (approx.)11.3%
Asset turnover1.31x
Leverage & solvency
Liabilities / assets59.7%
Debt / equity0.53x
Current ratio1.18x
Interest coverage5.15x
Cash quality & payout
Operating cash flow / net income1.80x
Accruals ratio-3.2%
Payout ratio—
Capex / revenue2.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $302.25M | $297.98M | $285.36M | $289.32M | $229.04M | $219.50M | $209.84M | $188.89M |
| Cost of revenue | $248.13M | $242.63M | $232.66M | $237.05M | $185.43M | $177.28M | $168.75M | $152.67M |
| Gross profit | $54.12M | $55.35M | $52.70M | $52.27M | $43.61M | $42.23M | $41.10M | $36.22M |
| SG&A expense | $20.63M | $21.61M | $19.69M | $19.34M | $19.30M | $17.60M | $14.84M | $13.87M |
| Operating income | $16.51M | $17.19M | $17.30M | $17.47M | $10.24M | $11.53M | $12.65M | $9.24M |
| Interest expense | $3.62M | $3.35M | $3.07M | $3.25M | $1.02M | $1.20M | $1.21M | $650,000 |
| Pretax income | $14.19M | $14.83M | $14.09M | $14.27M | $9.40M | $10.58M | $11.38M | $8.60M |
| Income tax | $3.12M | $3.94M | $3.79M | $3.90M | $2.52M | $2.60M | $2.85M | $2.07M |
| Net income | $9.64M | $9.08M | $8.52M | $8.64M | $6.08M | $7.08M | $7.78M | $5.76M |
| EBITDA | $20.20M | $20.30M | $19.92M | $19.83M | $12.30M | $13.75M | $14.54M | $11.06M |
| EPS (basic) | 0.28 | 0.26 | 0.25 | — | 0.18 | 0.21 | 0.23 | — |
| EPS (diluted) | 0.26 | 0.25 | 0.24 | — | 0.17 | 0.20 | 0.22 | — |
| Weighted avg. shares (diluted) | 36.38M | 35.96M | 35.76M | — | 35.27M | 35.37M | 35.20M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $18.39M | $15.27M | $4.91M | $17.02M | $2.34M | $14.38M | $5.22M | $24.25M |
| Receivables | $130.84M | $133.18M | $122.82M | $123.11M | $96.08M | $95.72M | $94.99M | $81.30M |
| Current assets | $179.07M | $183.59M | $152.82M | $167.41M | $113.97M | $127.37M | $123.89M | $122.86M |
| PP&E, net | $93.39M | $75.30M | $63.97M | $60.98M | $55.86M | $52.58M | $43.52M | $43.30M |
| Goodwill | $237.62M | $235.79M | $237.25M | $237.25M | $161.53M | $156.60M | $154.90M | $129.12M |
| Total assets | $1.04B | $1.04B | $956.48M | $968.18M | $753.64M | $751.42M | $743.62M | $679.52M |
| Current liabilities | $151.73M | $152.41M | $128.57M | $147.26M | $109.35M | $104.94M | $87.97M | $101.70M |
| Short-term debt | $5.00M | $5.00M | $5.00M | $5.00M | — | — | — | $0 |
| Long-term debt | $193.33M | $192.50M | $164.67M | $168.84M | $26.00M | $37.00M | $52.50M | $0 |
| Total debt | $198.33M | $197.50M | $169.67M | $173.84M | $26.00M | $37.00M | $52.50M | $0 |
| Total liabilities | $623.05M | $632.85M | $567.05M | $593.93M | $410.60M | $417.79M | $420.60M | $367.56M |
| Shareholders' equity | $375.82M | $359.20M | $346.01M | $332.60M | $321.91M | $313.30M | $303.60M | $293.28M |
| Net debt | $179.94M | $182.23M | $164.76M | $156.81M | $23.66M | $22.61M | $47.28M | -$24.25M |
| Shares outstanding | 35.07M | 34.85M | 34.75M | 34.63M | 34.57M | 34.49M | 34.45M | 34.37M |
| Cash flow statement | ||||||||
| Operating cash flow | $25.12M | $21.83M | -$3.40M | $20.96M | $13.92M | $34.64M | -$21.23M | $20.57M |
| Capital expenditure | $14.99M | $6.34M | $5.27M | $3.56M | $3.46M | $3.06M | $1.96M | $3.32M |
| Free cash flow | $10.13M | $15.49M | -$8.68M | $17.40M | $10.47M | $31.58M | -$23.19M | $17.25M |
| Investing cash flow | -$23.15M | -$39.92M | -$5.38M | -$153.02M | -$14.60M | -$10.05M | -$50.30M | -$4.40M |
| Financing cash flow | $1.14M | $28.45M | -$3.33M | $146.75M | -$11.38M | -$15.43M | $52.51M | $3.61M |
| Depreciation & amortization | $3.69M | $3.11M | $2.62M | $2.36M | $2.06M | $2.22M | $1.89M | $1.83M |
| Stock-based compensation | $3.32M | $2.95M | $2.52M | $2.16M | $2.45M | $2.18M | $2.15M | $2.36M |
Free plan shows the latest 8 periods; Pro shows all 35 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.